We are live on
!
Find out more
TD Asset Management Portfolio holdings
AUM
$123B
1-Year Est. Return
34.51%
This Fund
S&P 500
This Quarter
Est. Return
+8.43%
1 Year Est. Return
+34.51%
3 Year Est. Return
+98.94%
5 Year Est. Return
+122.3%
10 Year Est. Return
+375.56%
AUM
$113B
AUM Growth
+$6.09B
(+5.7%)
Cap. Flow
-$1.22B
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
25.52%
Holding
1,445
New
84
Increased
613
Reduced
589
Closed
60
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$252M |
| 2 |
UnitedHealth
UNH
|
+$220M |
| 3 |
Colgate-Palmolive
CL
|
+$213M |
| 4 |
Moody's
MCO
|
+$199M |
| 5 |
Curtiss-Wright
CW
|
+$172M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$727M |
| 2 |
Lam Research
LRCX
|
+$339M |
| 3 |
Merck
MRK
|
+$319M |
| 4 |
ConocoPhillips
COP
|
+$190M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$173M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.68% |
| 2 | Financials | 20.15% |
| 3 | Healthcare | 11.01% |
| 4 | Industrials | 10.63% |
| 5 | Consumer Discretionary | 7.46% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PDCO
1301
DELISTED
Patterson Companies, Inc.
PDCO
| $492K | ﹤0.01% |
22,200
| – | – |
|
|
RGLS
1302
DELISTED
Regulus Therapeutics
RGLS
| $486K | ﹤0.01% |
+302,000
| New | +$500K |
|
1303
Otter Tail
OTTR
$3.71B
| $476K | ﹤0.01% |
6,100
-2,600
| -30% | -$225K |
|
1304
Kyverna Therapeutics
KYTX
$444M
| $472K | ﹤0.01% |
90,242
| – | – |
|
1305
British American Tobacco
BTI
$131B
| $466K | ﹤0.01% |
12,659
+210
| +2% | +$7.5K |
|
|
BLFY
1306
DELISTED
Blue Foundry Bancorp
BLFY
| $466K | ﹤0.01% |
44,650
| – | – |
|
1307
InterDigital
IDCC
$7.87B
| $465K | ﹤0.01% |
3,300
-1,500
| -31% | -$197K |
|
|
NOA
1308
North American Construction
NOA
$369M
| $465K | ﹤0.01% |
24,668
-20
| -0.1% | -$378 |
|
1309
Orchestra BioMed
OBIO
$238M
| $465K | ﹤0.01% |
92,678
| – | – |
|
1310
National Grid
NGG
$80.4B
| $461K | ﹤0.01% |
7,017
+42
| +0.6% | +$2.57K |
|
1311
Bio-Rad Laboratories Class A
BIO
$8.71B
| $448K | ﹤0.01% |
1,349
-4,001
| -75% | -$1.27M |
|
|
CLYM
1312
Climb Bio
CLYM
$681M
| $445K | ﹤0.01% |
+89,400
| New | +$632K |
|
1313
Janux Therapeutics
JANX
$925M
| $441K | ﹤0.01% |
9,534
-10,266
| -52% | -$447K |
|
|
COOP
1314
DELISTED
Mr. Cooper
COOP
| $437K | ﹤0.01% |
4,800
-700
| -13% | -$62K |
|
|
SAGE
1315
DELISTED
Sage Therapeutics
SAGE
| $419K | ﹤0.01% |
57,474
| – | – |
|
1316
DNOW Inc
DNOW
$2.58B
| $417K | ﹤0.01% |
32,500
-12,000
| -27% | -$159K |
|
|
VSTO
1317
DELISTED
Vista Outdoor Inc.
VSTO
| $413K | ﹤0.01% |
10,500
| – | – |
|
1318
TTM Technologies
TTMI
$12B
| $407K | ﹤0.01% |
+21,900
| New | +$423K |
|
1319
Immuneering
IMRX
$267M
| $401K | ﹤0.01% |
150,876
| – | – |
|
|
LAR
1320
Lithium Argentina AG
LAR
$985M
| $401K | ﹤0.01% |
123,028
+253
| +0.2% | +$702 |
|
1321
Quanex
NX
$819M
| $398K | ﹤0.01% |
14,400
-9,800
| -40% | -$279K |
|
1322
Xponential Fitness
XPOF
$273M
| $398K | ﹤0.01% |
+32,400
| New | +$476K |
|
|
OBE
1323
Obsidian Energy
OBE
$716M
| $398K | ﹤0.01% |
72,067
-1,107
| -2% | -$7.42K |
|
1324
Zentalis Pharmaceuticals
ZNTL
$337M
| $398K | ﹤0.01% |
106,080
+3,200
| +3% | +$11.6K |
|
1325
Custom Truck One Source
CTOS
$2.31B
| $396K | ﹤0.01% |
+110,048
| New | +$463K |
|
Similar funds
VAM
TD Asset Management's Q3 2024 Portfolio in Review
As of Q3 2024, TD Asset Management held 1,445 positions worth $113B, up 5.7% from $107B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
TD Asset Management's Q3 2024 filing shows 84 new, 613 increased, 589 reduced and 60 closed positions. Its largest new stake was Invesco S&P 500 Equal Weight ETF: 776,776 shares worth $139M. The largest sale was iShares 20+ Year Treasury Bond ETF, an estimated $727M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, down from 22% a quarter earlier, followed by Financials and Healthcare.
- TD Asset Management's largest Q3 2024 buy was Invesco S&P 500 Equal Weight ETF: 776,776 shares worth $139M.
- TD Asset Management added most to Apple in Q3 2024, an estimated $252M increase.
- TD Asset Management's biggest Q3 2024 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $727M.
- TD Asset Management fully exited Lam Research in Q3 2024, selling an estimated $339M.
- TD Asset Management's ten largest holdings make up 26% of its $113B portfolio in Q3 2024.
- TD Asset Management opened 84 new positions and closed 60 in Q3 2024.
- TD Asset Management's portfolio value rose 5.7% quarter-over-quarter to $113B.
Based on TD Asset Management's 13F filing for Q3 2024, filed 1 Nov 2024.